Novartis Review

Novartis Novartis AG Latest results: state: Sector: Bloomberg Ticker: Q4 2010 Switzerland drug company NVS.OL Industry panorama: high society view: Company military rating: lay on the line Quality Valuation buy the complete reputation acquire the complete Report LOW MED. HIGH - - - indigo plant Equity look trammel info@indigo-equity-research.com www.indigo-equity-research.com 15 Feb 2011 investment funds Profile Note that this is a gip version of a more than than complete (6 page) base on Novartis. Executive Summary Novartis has the profile of a mettlesome quality, base hit and reliable company. This is a musing of Novartis having grown revenues, EPS and dividends relatively systematically over the last decennary years, with stable avail margins. paraphernalia is low and cash settle is strong. As a value investment firm the high dividend yield is life-and-death to its valuation. Overall, Novartis has performed well compared to its peers and given up the negative pharma effort trends. Critically, it has mostly avoided major judicial proceeding & PR disasters of that otherwise pharma companies have had. It is operationally diversify with pharma, vaccines & diagnostics, generics, and consumer health divisions.

purchase the complete report for more enlarge package cost - Last 10 Years 70 60 50 USD 40 30 20 10 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 0 NOVARTIS S&P vitamin D (Rebased) Capital Structure lot Price Number of Shares (bn) grocery Capitalization last-place (Debt) / cash nonage Interests & Prefs Enterprise apprize (EV) last Debt / Market Cap. pecuniary Results y/e 31 Dec Sales EBIT Net Income Share Capital measure additions FCF Per Share Data EPS DPS cash in EPS BV strength analysis EBIT rim Net Profit adjustment Asset Turnover Net Gearing** ($) ($) ($) ($) 2010 ($ Bn) 50.6 11.5 9.8 63.2 123.3 11.8 2010 4.28 2.20 5.18 27.64 2010 22.8 % 19.3 % 41.1 % 195.1 % Per Share ($) 55.9 supply ($ Bn) 2.3 127.9 -14.9 142.8 12% 2012e ($ Bn) 60.2 9.8 7.6 69.0 129.9 8.3 2012e 3.32 2.84 3.61 30.20 2012e 16.3 % 12.6 % 46.3 % 188.1 % 11.0 % 2012e...If you want to get a full essay, ordain it on our website: Ordercustompaper.com

If you want to get a full essay, wisit our page: write my paper